Skip to main content

Table 3 Comparison of postoperative events

From: Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial

Postoperative indices

IVR group (n = 44)

IVC group (n = 46)

P value

VH recurrence, n (%)

5 (11.4)

6 (13.0)

0.808

NVG occurrence, n (%)

2 (4.5)

2 (4.3)

0.964

Recurrent retinal detachment, n (%)

2 (4.5)

1 (2.2)

0.531

Postoperative fibrovascular proliferation progression, n (%)

2 (4.5)

3 (6.5)

0.682

Reoperation, n (%)

3 (6.8)

3 (6.5)

0.955

  1. IVR = intravitreal ranibizumab; IVC = intravitreal conbercept; VH = vitreous hemorrhage; NVG = neovascular glaucoma